TP53 and lung cancer: Both antigens and autoantibodies to antigens involved in DNA repair pathways, such as p53 [34]–[36] and Ku [37]–[39], have been highlighted as factors involved in tumorigenesis and as biomarkers in lung cancer, breast cancer, and leukemia.